SCHEMBL1991573

SCHEMBL1991573

CCOC(=O)Cc1nc(Cl)nc2c(C)cccc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
TDP1 Q9NUW8 2/20 0.51
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
RECQL P46063 1/20 0.44
POLB P06746 1/20 0.41
LMNA P02545 1/20 0.41
CHEK1 O14757 1/20 0.41
MAPK1 P28482 1/20 0.41
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
PKM P14618 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RAB9A P51151 1/20 0.38
TSHR P16473 1/20 0.38
CYP1A2 P05177 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31647297 0.81 ALDH1A1 (0.51) KDM4ETDP1ALDH1A1SMN1; SMN2RECQL
SCHEMBL1991935 0.79 HSD17B10 (0.44) KDM4ETDP1ALDH1A1SMN1; SMN2RECQL
SCHEMBL1996197 0.77 HRH4 (0.45) KDM4ETDP1SMN1; SMN2RECQLKMT2A
SCHEMBL1993219 0.74 KDM4E (0.49) KDM4ETDP1ALDH1A1SMN1; SMN2POLB
SCHEMBL2215224 0.73 ALDH1A1 (0.51) KDM4ETDP1ALDH1A1SMN1; SMN2RECQL
SCHEMBL1990509 0.73 LATS1 (0.42) KDM4EALDH1A1SMN1; SMN2RECQLHSD17B10
SCHEMBL1989725 0.73 ALDH1A1 (0.46) KDM4EALDH1A1SMN1; SMN2LMNAMAPK1
SCHEMBL1993736 0.72 ALDH1A1 (0.48) KDM4ETDP1ALDH1A1SMN1; SMN2POLB
SCHEMBL31125298 0.71 PRNP (0.47) KDM4ETDP1ALDH1A1SMN1; SMN2POLB
SCHEMBL165394 0.70 KDM4E (0.47) KDM4ETDP1ALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS ABBOTT LABORATORIES (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152243-A1 NOVEL THIENOPYRROLE COMPOUNDS TPMT, TSLP, THPO KDM4E 3351/4885TDP1 2210/4885ALDH1A1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.